Eucrates Biomedical Acquisition Corp. Unit
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch EUCRU and buy or sell other stocks, ETFs, and their options commission-free!About EUCRU
Eucrates Biomedical Acquisition Corp. operates as a blank Check company focusing on acquiring, engaging in a share exchange, share reconstruction and amalgamations. The company was founded by Stelios Papadopoulos, Parag Saxena, Evangelos Vergetis and Daphne Karydas on August 21, 2020 and is headquartered in New York, NY.
CEOParag Phoolchand Saxena, MBA
CEOParag Phoolchand Saxena, MBA
Employees—
Employees—
HeadquartersNew York, New York
HeadquartersNew York, New York
Founded2020
Founded2020
Employees—
Employees—
EUCRU Key Statistics
Market cap42.14M
Market cap42.14M
Price-Earnings ratio53.35
Price-Earnings ratio53.35
Dividend yield—
Dividend yield—
Average volume2.74K
Average volume2.74K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$10.67
52 Week high$10.67
52 Week low$9.76
52 Week low$9.76
Stock Snapshot
The current Eucrates Biomedical Acquisition Corp. Unit(EUCRU) stock price is $10.02, with a market capitalization of 42.14M. The stock trades at a price-to-earnings (P/E) ratio of 53.35.
During the trading day, Eucrates Biomedical Acquisition Corp. Unit(EUCRU) stock saw an opening price of —, a peak of —, and a bottom of —.
Trading activity shows a volume of 0, compared to an average daily volume of 2.74K.
Over the past 52 weeks, Eucrates Biomedical Acquisition Corp. Unit(EUCRU) stock has traded between a high of $10.67 and a low of $9.76.
Over the past 52 weeks, Eucrates Biomedical Acquisition Corp. Unit(EUCRU) stock has traded between a high of $10.67 and a low of $9.76.